Bu Gyeom Kim

516 total citations
17 papers, 387 citations indexed

About

Bu Gyeom Kim is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Bu Gyeom Kim has authored 17 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Bu Gyeom Kim's work include Endoplasmic Reticulum Stress and Disease (4 papers), Cannabis and Cannabinoid Research (4 papers) and Autophagy in Disease and Therapy (4 papers). Bu Gyeom Kim is often cited by papers focused on Endoplasmic Reticulum Stress and Disease (4 papers), Cannabis and Cannabinoid Research (4 papers) and Autophagy in Disease and Therapy (4 papers). Bu Gyeom Kim collaborates with scholars based in South Korea, United States and Japan. Bu Gyeom Kim's co-authors include Sang Cheul Oh, Soyeon Jeong, Dae Yeong Kim, Dae-Hee Lee, Min Jee Jo, Hye Kyeong Yun, Jung Lim Kim, Seong Hye Park, Yoon A Jeong and Yoo Jin Na and has published in prestigious journals such as Cancer Research, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Bu Gyeom Kim

16 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bu Gyeom Kim South Korea 11 187 145 74 66 60 17 387
Dae Yeong Kim South Korea 11 220 1.2× 230 1.6× 81 1.1× 77 1.2× 71 1.2× 18 508
Ornella Pellerito Italy 14 216 1.2× 164 1.1× 51 0.7× 59 0.9× 84 1.4× 19 504
Su-Chan Lee South Korea 13 202 1.1× 89 0.6× 43 0.6× 43 0.7× 49 0.8× 23 407
Hye Kyeong Yun South Korea 14 264 1.4× 229 1.6× 97 1.3× 95 1.4× 89 1.5× 18 570
Yuan Dong China 11 210 1.1× 62 0.4× 95 1.3× 57 0.9× 63 1.1× 31 415
Shengfu Huang China 9 121 0.6× 131 0.9× 33 0.4× 49 0.7× 41 0.7× 18 390
Yi‐Hsuan Lin Taiwan 9 211 1.1× 75 0.5× 35 0.5× 48 0.7× 67 1.1× 20 398
Dewu Zhong China 14 244 1.3× 138 1.0× 111 1.5× 129 2.0× 67 1.1× 36 634
Jianyun Zhou China 11 200 1.1× 41 0.3× 142 1.9× 58 0.9× 52 0.9× 21 420
Toshiyuki Takahashi Japan 8 208 1.1× 63 0.4× 73 1.0× 106 1.6× 21 0.3× 16 409

Countries citing papers authored by Bu Gyeom Kim

Since Specialization
Citations

This map shows the geographic impact of Bu Gyeom Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bu Gyeom Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bu Gyeom Kim more than expected).

Fields of papers citing papers by Bu Gyeom Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bu Gyeom Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bu Gyeom Kim. The network helps show where Bu Gyeom Kim may publish in the future.

Co-authorship network of co-authors of Bu Gyeom Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Bu Gyeom Kim. A scholar is included among the top collaborators of Bu Gyeom Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bu Gyeom Kim. Bu Gyeom Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kim, Bo Hyun, Dae Joon Kim, Bu Gyeom Kim, et al.. (2024). Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell lines. International Journal of Oncology. 64(6). 1 indexed citations
2.
Kim, Bu Gyeom, Dae Yeong Kim, Woo Young Kim, et al.. (2024). Cannabidiol Enhances Atezolizumab Efficacy by Upregulating PD-L1 Expression via the cGAS–STING Pathway in Triple-Negative Breast Cancer Cells. Cancer Immunology Research. 12(12). 1796–1807. 7 indexed citations
3.
Kim, Bu Gyeom, Bo Ram Kim, Dae Yeong Kim, et al.. (2024). Abstract 5548: Cannabidiol enhances efficacy of atezolizumab via upregulation of PD-L1 expression by cGAS-STING pathway in triple negative breast cancer cells. Cancer Research. 84(6_Supplement). 5548–5548. 1 indexed citations
4.
Jeong, Soyeon, Hye Kyeong Yun, Yoon A Jeong, et al.. (2022). AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer Cells. Cancers. 14(13). 3043–3043. 4 indexed citations
5.
Jo, Min Jee, Bu Gyeom Kim, Woo Young Kim, et al.. (2021). Cannabidiol Suppresses Angiogenesis and Stemness of Breast Cancer Cells by Downregulation of Hypoxia-Inducible Factors-1α. Cancers. 13(22). 5667–5667. 26 indexed citations
6.
Jo, Min Jee, Bu Gyeom Kim, Seong Hye Park, et al.. (2020). Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer. Cancers. 12(9). 2358–2358. 10 indexed citations
7.
Jeong, Yoon A, Bo Ram Kim, Dae Young Kim, et al.. (2019). Korean Red Ginseng Extract Increases Apoptosis by Activation of the Noxa Pathway in Colorectal Cancer. Nutrients. 11(9). 2026–2026. 5 indexed citations
8.
Jo, Min Jee, Soyeon Jeong, Hye Kyeong Yun, et al.. (2019). Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer. BMC Cancer. 19(1). 739–739. 37 indexed citations
9.
Park, Seong Hye, Soyeon Jeong, Bo Ram Kim, et al.. (2019). Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer. Oncogene. 39(1). 136–150. 32 indexed citations
10.
Jeong, Soyeon, Min Jee Jo, Hye Kyeong Yun, et al.. (2019). Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer. Cell Death and Disease. 10(11). 846–846. 69 indexed citations
11.
Jeong, Soyeon, Dae Yeong Kim, Sanghee Kang, et al.. (2019). Docosahexaenoic Acid Enhances Oxaliplatin-Induced Autophagic Cell Death via the ER Stress/Sesn2 Pathway in Colorectal Cancer. Cancers. 11(7). 982–982. 36 indexed citations
12.
Park, Seong Hye, Min Jee Jo, Bo Ram Kim, et al.. (2019). Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer. Theranostics. 9(8). 2235–2251. 28 indexed citations
13.
Kim, Jung Lim, Seong Hye Park, Soyeon Jeong, et al.. (2019). Sea Cucumber (Stichopus japonicas) F2 Enhanced TRAIL-Induced Apoptosis via XIAP Ubiquitination and ER Stress in Colorectal Cancer Cells. Nutrients. 11(5). 1061–1061. 14 indexed citations
14.
Kim, Jung Lim, Bo Ram Kim, Dae Yeong Kim, et al.. (2019). Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer. Cancers. 11(5). 642–642. 28 indexed citations
15.
Yun, Hye Kyeong, Soyeon Jeong, Yoon A Jeong, et al.. (2019). Abstract 714: Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells. Cancer Research. 79(13_Supplement). 714–714. 2 indexed citations
16.
Jeong, Soyeon, Bu Gyeom Kim, Dae Yeong Kim, et al.. (2019). Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells. Cancers. 11(6). 781–781. 70 indexed citations
17.
Park, Seong Hye, Jung Lim Kim, Soyeon Jeong, et al.. (2018). Codium fragile F2 sensitize colorectal cancer cells to TRAIL-induced apoptosis via c-FLIP ubiquitination. Biochemical and Biophysical Research Communications. 508(1). 1–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026